Home/Pipeline/SPRINT PNS for Postoperative Acute Pain

SPRINT PNS for Postoperative Acute Pain

Acute Pain following surgery (e.g., Total Knee Arthroplasty)

InvestigationalActive

Key Facts

Indication
Acute Pain following surgery (e.g., Total Knee Arthroplasty)
Phase
Investigational
Status
Active
Company

About SPR Therapeutics

SPR Therapeutics is a commercial-stage medical device innovator addressing the critical need for non-opioid chronic pain therapies through its proprietary peripheral nerve stimulation platform. The company's SPRINT® PNS System differentiates itself with a minimally invasive, temporary lead placement and a 60-day treatment regimen, aiming to provide lasting pain relief without permanent implants. Having secured FDA clearances for multiple pain indications, SPR is executing a commercial rollout in the U.S. while continuing to expand its clinical evidence and explore new applications. The company operates in a high-growth market driven by the opioid crisis and demand for effective, non-addictive pain management solutions.

View full company profile

Therapeutic Areas